JOEL FERGUSON: Open Payments
NPI 1932565561 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 12 payments from 7 companies in 2025. Trend: 2023 $298 · 2024 $340 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $84 |
| Ascensia Diabetes Care Us Inc. | 1 | $44 |
| Medtronic, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| BETA BIONICS, INC. | 1 | $15 |
Products named: Kerendia, Ozempic, GVOKE HYPOPEN, MINIMED 780G, INTELLIS ADAPTIVESTIM, TZIELD, iLet Bionic Pancreas.
Industry payments across IN — which companies pay providers there.
